MedTech, Biopharma, and Clinical Software Lead October 2025 Healthcare Transactions

Tags:

In October, healthcare transactions surged past $50 billion, marking another active month across medical devices, pharmaceutical services, biotech, and elder care. Private equity and strategic buyers leaned into high-growth platforms, software-enabled innovation, and specialty care networks.

Key Insights:

  • MedTech Megadeal: Blackstone and TPG’s $18.3B take-private of Hologic led the month, underscoring investor conviction in diagnostics and women’s health technologies.
  • Clinical Trial Tech Scales: Thermo Fisher acquired Clario for $8.9B, expanding its footprint in digital trial management and data-centric R&D execution.
  • Biotech Momentum: Novo Nordisk’s $5.2B purchase of Akero Therapeutics, plus acquisitions by Alkermes ($2.1B) and Ipsen ($1.2B), reflect sustained appetite for precision therapies and chronic disease innovation.
  • Senior Care Consolidation: StepStone and GREYKITE recapitalized Vitalia Home for $1.7B, and PureHealth’s $933M investment into Hellenic Healthcare signals rising interest in long-term care and regional delivery networks.
  • AI & Digital Health Expansion: OpenEvidence raised $200M for its AI-powered medical platform, emphasizing investor focus on interoperability, virtual care, and data-driven decision support.

Download the full October 2025 Healthcare Transactions Report!

Written By: Dakota